EBioMedicine

The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.

Publisher
Elsevier
Website
http://www.ebiomedicine.com/

Some content from Wikipedia, licensed under CC BY-SA

HIV & AIDS

HIV: An antidiabetic drug to reduce chronic inflammation

Metformin, a drug used to treat type-2 diabetes, could help reduce chronic inflammation in people living with HIV (PLWH) who are being treated with antiretroviral therapy (ART), according to researchers at the University ...

Medications

Do known drugs help against SARS-CoV-2?

There are no therapeutics available that have been developed for COVID-19 treatment.Repurposing of already available medication for COVID-19 therapy is an attractive option to shorten the road to treatment development. The ...

Neuroscience

Scientists develop novel immune diagnostics of multiple sclerosis

Multiple sclerosis (MS) is the most common neurological disease in young adults, affecting more than 2 million individuals worldwide, with about 1500 cases in Estonia. About 20% of MS patients experience optic neuritis (ON) ...

Arthritis & Rheumatism

Cartilage matrix as natural biomaterial for cartilage regeneration

Just a few millimeters thick, articular cartilage plays a crucial role in our musculoskeletal system, since it is responsible for smooth (in the truest sense of the word) movement. However, the downside of its particular ...

page 1 from 17